Fitness trade-offs in the evolution of dihydrofolate reductase and drug resistance in Plasmodium falciparum.
Patterns of emerging drug resistance reflect the underlying adaptive landscapes for specific drugs. In Plasmodium falciparum, the parasite that causes the most serious form of malaria, antifolate drugs inhibit the function of essential enzymes in the folate pathway. However, a handful of mutations i...
Main Authors: | Marna S Costanzo, Kyle M Brown, Daniel L Hartl |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3100297?pdf=render |
Similar Items
-
Selection of drug resistant mutants from random library of <it>Plasmodium falciparum </it>dihydrofolate reductase in <it>Plasmodium berghei </it>model
by: Yuthavong Yongyuth, et al.
Published: (2011-05-01) -
Dihydrofolate Reductase I164L Mutation in Plasmodium falciparum, Madagascar
by: Didier Ménard, et al.
Published: (2008-07-01) -
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon Region of Brazil
by: KF Vasconcelos, et al.
Published: (2000-10-01) -
The implication of <it>dihydrofolate reductase </it>and <it>dihydropteroate synthetase </it>gene mutations in modification of <it>Plasmodium falciparum </it>characteristics
by: Elbashir Mustafa I, et al.
Published: (2007-08-01) -
Evaluation of dihydrofolate reductase and dihydropteroate synthetase genotypes that confer resistance to sulphadoxine-pyrimethamine in <it>Plasmodium falciparum</it> in Haiti
by: Carter Tamar E, et al.
Published: (2012-08-01)